Prognostic factors in progressive high-grade glial tumors treated with systemic approach: A single center experience.

doi:10.1177/1078155220920684

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Prognostic factors in progressive high-grade glial tumors treated with systemic approach: A single center experience.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners - 1 Mar 2021

Alan Ozkan, Telli Tugba Akin, Tuylu Tugba Basoglu, Arikan Rukiye, Demircan Nazım Can, Ercelep Ozlem, Kaya Serap, Babacan Nalan Akgul, Atasoy Beste M, Bozkurt Suheyla, Bayri Yasar, Gul Dilek, Ekinci Gazanfer, Ziyal Ibrahim, Dane Faysal, Yumuk P Fulden

Abstract excerpt

PURPOSE: Malignant high-grade gliomas are the most common and aggressive type of primary brain tumor, and the prognosis is generally extremely poor. In this retrospective study, we analyzed the outcome of systemic treatment in recurrent high-grade glioma patients and the impact of prognostic factors on survivals. METHODS: Data from 114 patients with recurrent high-grade glioma who received systemic treatment and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioblastoma

Share to Isocitrate Dehydrogenase

Share to Neoplasm Grading

Share to Neoplasm Recurrence, Local

Share to Progression-Free Survival

Share to Survival Rate

Share to X-linked Nuclear Protein

Source

Open in PubMed

Identifiers

PMID: 32349641
DOI: 10.1177/1078155220920684

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic factors in progressive high-grade glial tumors treated with systemic approach: A single center experience.PMID 32349641Read ↗

Overview of prognostic factors in adult glioma; a 10-year experience at a single institutionSemantic proximity Read ↗

Diagnosis and management of multiple high-grade gliomas: a retrospective studySemantic proximity Read ↗

Genomic Profiling in Glioma Patients to Explore Clinically Relevant Markers.Semantic proximity Read ↗

Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.Semantic proximity Read ↗

Molecular Characteristics of Thalamic Gliomas in Adults.Semantic proximity Read ↗

Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011-2017): a multicenter retrospective study from CGGA.Semantic proximity Read ↗

Anaplastic Astrocytoma: State of the art and future directions.Semantic proximity Read ↗

New molecular prognostic factors of adult diffuse lower-grade gliomas in post-2016 molecular era: a retrospective analysis from single center.Semantic proximity Read ↗

Local and systemic effects of IDH mutations on primary glioma patients.Semantic proximity Read ↗

Prognostic Value of a Nomogram Model Based on Tumor Immune Markers and Clinical Factors for Adult Primary GliomasSemantic proximity Read ↗

Risk Stratification in Low Grade Glioma: A Single Institutional Experience.Semantic proximity Read ↗

Molecular Classification Defines 4 Prognostically Distinct Glioma Groups Irrespective of Diagnosis and GradeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.